Serum Anti-Mullerian Hormone Levels Might Indicate Premenopausal Endometrial Lesions

被引:0
|
作者
Yao, Yingsha [1 ]
Shi, Liujing [1 ]
Zhu, Xiaoming [1 ,2 ]
机构
[1] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou 310006, Peoples R China
[2] Zhejiang Univ, Womens Hosp, Sch Med, Key Lab Womens Reprod Hlth Zhejiang Prov, Hangzhou 310006, Peoples R China
关键词
polycystic ovary syndrome; endometrial proliferative lesions; anti-Mullerian hormone; threshold value; regression model; POLYCYSTIC-OVARY-SYNDROME; CANCER STATISTICS; RISK; HYPERPLASIA; ULTRASOUND; PREDICTION; CONSENSUS; CRITERIA; CA125; HE-4;
D O I
10.3390/diagnostics13213301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Endometrial proliferative lesions (EPL) usually refer to endometrial hyperplasia (EH) and endometrial cancer (EC). Among patients with premenopausal EPL who wish to preserve their fertility, only those with EH and early-stage EC have the possibility to undergo fertility preservation therapy. However, there is currently a lack of specific and reliable screening criteria and models for identifying these patients. Methods: This study utilized a retrospective diagnostic study design. The training set included medical record information that met the criteria between August 2017 and October 2022, while the validation set consisted of medical record information that met the criteria from November 2022 to May 2023. The endometrial pathological test served as the gold standard. The serum anti-Mullerian hormone (AMH) level before endometrial sampling and a regression model were employed to predict EPL. Results: The study included a total of 1209 patients with PCOS (1119 in the control group and 90 in the endometrial proliferative lesion group) and 5366 women without PCOS (5249 in the control group and 117 in the proliferative lesion group). In the case of PCOS patients aged 20-39 years, the most effective screening threshold for AMH was found to be a serum AMH level of <= 5.39 ng/mL. The model used for this group was logit(p) = -2.562 - 0.430 x AMH + 0.127 x BMI + 1.512 x hypertension + 0.956 x diabetes -1.145 x regular menstruation. On the other hand, for non-PCOS women aged 20-39 years, the optimal screening threshold for AMH was determined to be a serum AMH value of <= 2.18 ng/mL. The model used for this group was logit(p) = -3.778 - 0.823 x AMH + 0.176 x BMI + 2.660 x diabetes -1.527 x regular menstruation -1.117 x dysmenorrhea. It is important to note that all of these findings have successfully passed internal verification. Conclusion: For PCOS and non-PCOS women aged 20-39 years, the serum AMH test and related multiple regression models were obtained for the warning of EPL.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Serum anti-mullerian hormone levels and age among Samoan women
    O'Brien, Grace
    Lambert-Messerlian, Geralyn
    Hawley, Nicola L.
    Fidow, Ulai T.
    Naseri, Take
    Reupena, Muagututi'a Sefuiva
    Kershaw, Erin E.
    Azar, Marinelle B.
    Pangburn, Martha M.
    Mcgarvey, Stephen T.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2025, 23 (01)
  • [2] Serum testosterone levels are positively associated with serum anti-mullerian hormone levels in infertile women
    Lin, Li-Te
    Li, Chia-Jung
    Tsui, Kuan-Hao
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [3] Anti-Mullerian hormone levels in nurses working night shifts
    Johnson, Candice Y.
    Tanz, Lauren J.
    Lawson, Christina C.
    Howards, Penelope P.
    Bertone-Johnson, Elizabeth R.
    Eliassen, A. Heather
    Schernhammer, Eva S.
    Rich-Edwards, Janet W.
    ARCHIVES OF ENVIRONMENTAL & OCCUPATIONAL HEALTH, 2020, 75 (03) : 136 - 143
  • [4] The Role of Serum Anti-Mullerian Hormone Measurement in the Diagnosis of Polycystic Ovary Syndrome
    Sivanandy, Mala S.
    Ha, Sierra K.
    DIAGNOSTICS, 2023, 13 (05)
  • [5] The relationship between serum anti-mullerian hormone levels and puberty in girls with obesity
    Sarikaya, Emre
    Cicek, Dilek
    Kara, Leyla
    Gok, Ebru Suman
    Berber, Ugur
    Siraz, Ulkue Gul
    Muhtaroglu, Sabahattin
    Hatipoglu, Nihal
    TRENDS IN PEDIATRICS, 2024, 5 (03): : 79 - 84
  • [6] Testosterone and androstenedione are positively associated with anti-Mullerian hormone in premenopausal women
    Islam, Rakibul M.
    Bell, Robin J.
    Skiba, Marina A.
    Davis, Susan R.
    CLINICAL ENDOCRINOLOGY, 2021, 95 (05) : 752 - 759
  • [7] Clinical application of serum anti-Mullerian hormone in women
    Oh, So Ra
    Choe, Sun Yi
    Cho, Yeon Jean
    CLINICAL AND EXPERIMENTAL REPRODUCTIVE MEDICINE-CERM, 2019, 46 (02): : 50 - 59
  • [8] Anti-Mullerian Hormone Levels among Female Firefighters
    Davidson, Samantha
    Jahnke, Sara
    Jung, Alesia M.
    Burgess, Jefferey L.
    Jacobs, Elizabeth T.
    Billheimer, Dean
    Farland, Leslie V.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (10)
  • [9] The role of serum anti-Mullerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome
    Casadei, Luisa
    Madrigale, Alessandra
    Puca, Francesco
    Manicuti, Claudia
    Emidi, Emanuela
    Piccione, Emilio
    Dewailly, Didier
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (06) : 545 - 550
  • [10] Assessment of anti-Mullerian hormone levels in premenopausal patients with systemic lupus erythematosus
    Gasparin, A. A.
    Souza, L.
    Siebert, M.
    Xavier, R. M.
    Chakr, R. M. S.
    Palominos, P. E.
    Brenol, J. C. T.
    Monticielo, O. A.
    LUPUS, 2016, 25 (03) : 227 - 232